/
Check out this week’s QuadCast as we highlight recent reporting from ESMO on best approach to potentially resectable pancreatic cancer, optimal timing of post-op radiosurgery for resected brain mets, the efficacy of dostarlimab on mismatch repair deficient tumors, and more.
